KR20240019074A - 분변 검체의 검사 방법 및 그것을 위한 이뮤노크로마토그래피 시험편 - Google Patents
분변 검체의 검사 방법 및 그것을 위한 이뮤노크로마토그래피 시험편 Download PDFInfo
- Publication number
- KR20240019074A KR20240019074A KR1020237038259A KR20237038259A KR20240019074A KR 20240019074 A KR20240019074 A KR 20240019074A KR 1020237038259 A KR1020237038259 A KR 1020237038259A KR 20237038259 A KR20237038259 A KR 20237038259A KR 20240019074 A KR20240019074 A KR 20240019074A
- Authority
- KR
- South Korea
- Prior art keywords
- sample
- antibody
- test piece
- immunochromatography
- fecal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 69
- 230000002550 fecal effect Effects 0.000 title claims abstract description 43
- 238000003317 immunochromatography Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 28
- AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 239000000725 suspension Substances 0.000 claims description 19
- 241001263478 Norovirus Species 0.000 claims description 13
- 239000000126 substance Substances 0.000 abstract description 22
- 238000005259 measurement Methods 0.000 abstract description 7
- 230000002452 interceptive effect Effects 0.000 abstract description 5
- 239000002245 particle Substances 0.000 description 24
- 238000001514 detection method Methods 0.000 description 21
- 239000012528 membrane Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 17
- 239000000427 antigen Substances 0.000 description 13
- 108091007433 antigens Proteins 0.000 description 13
- 102000036639 antigens Human genes 0.000 description 13
- 239000004793 Polystyrene Substances 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 239000004745 nonwoven fabric Substances 0.000 description 12
- 229920002223 polystyrene Polymers 0.000 description 12
- 239000000020 Nitrocellulose Substances 0.000 description 10
- 229920001220 nitrocellulos Polymers 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- CYKYBWRSLLXBOW-VTBMCCKRSA-N 2-hydroxy-1-[(3s,5s,8r,9s,10s,13s,14s,17s)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]ethanone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CC[C@H]21 CYKYBWRSLLXBOW-VTBMCCKRSA-N 0.000 description 7
- 230000008021 deposition Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000003365 glass fiber Substances 0.000 description 5
- 238000004062 sedimentation Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000011536 extraction buffer Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229920002799 BoPET Polymers 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001470 polyketone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical class [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 description 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- -1 support Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2021-095332 | 2021-06-07 | ||
| JP2021095332 | 2021-06-07 | ||
| PCT/JP2022/022712 WO2022259990A1 (ja) | 2021-06-07 | 2022-06-06 | 糞便検体の検査方法及びそのためのイムノクロマト試験片 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240019074A true KR20240019074A (ko) | 2024-02-14 |
Family
ID=84425012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237038259A Pending KR20240019074A (ko) | 2021-06-07 | 2022-06-06 | 분변 검체의 검사 방법 및 그것을 위한 이뮤노크로마토그래피 시험편 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240272158A1 (https=) |
| EP (1) | EP4350353A4 (https=) |
| JP (1) | JPWO2022259990A1 (https=) |
| KR (1) | KR20240019074A (https=) |
| TW (1) | TWI878683B (https=) |
| WO (1) | WO2022259990A1 (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008203135A (ja) | 2007-02-21 | 2008-09-04 | Denka Seiken Co Ltd | 検査デバイスの標識体部の形成方法及びラテラルフロー免疫測定用検査デバイス |
| JP2008268043A (ja) | 2007-04-23 | 2008-11-06 | Denka Seiken Co Ltd | 検査デバイスの検出部の形成方法及びラテラルフロー免疫測定用検査デバイス |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012050391A (ja) * | 2010-09-02 | 2012-03-15 | Life:Kk | 便検体から細菌類を検出する方法 |
| JP5416159B2 (ja) * | 2011-03-31 | 2014-02-12 | 富士フイルム株式会社 | 高感度なイムノクロマトグラフ方法 |
| ES2526137B1 (es) * | 2013-07-02 | 2015-12-02 | Certest Biotec, S.L. | Dispositivo para el diagnóstico de infección por Clostridium difficile |
| ES2538597B1 (es) * | 2013-12-20 | 2016-05-12 | Certest Biotec, S.L. | Dispositivo para la detección de Shigella dysenteriae serotipo 1 |
| US20190101532A1 (en) * | 2016-03-23 | 2019-04-04 | Denka Seiken Co., Ltd. | Method for forming sample addition part of immunochromatographic test device and immunochromatographic test device |
| WO2018012517A1 (ja) * | 2016-07-13 | 2018-01-18 | 積水メディカル株式会社 | イムノクロマトグラフィーを利用した検出方法 |
| JP6889535B2 (ja) * | 2016-10-05 | 2021-06-18 | デンカ株式会社 | 赤血球の凝集方法及び分離方法並びに赤血球凝集用試薬 |
| WO2019138899A1 (ja) * | 2018-01-11 | 2019-07-18 | 東洋紡株式会社 | 測定試料希釈液およびキットおよび測定方法 |
-
2022
- 2022-06-06 JP JP2023527842A patent/JPWO2022259990A1/ja active Pending
- 2022-06-06 US US18/566,740 patent/US20240272158A1/en active Pending
- 2022-06-06 WO PCT/JP2022/022712 patent/WO2022259990A1/ja not_active Ceased
- 2022-06-06 KR KR1020237038259A patent/KR20240019074A/ko active Pending
- 2022-06-06 EP EP22820171.1A patent/EP4350353A4/en active Pending
- 2022-06-06 TW TW111120811A patent/TWI878683B/zh active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008203135A (ja) | 2007-02-21 | 2008-09-04 | Denka Seiken Co Ltd | 検査デバイスの標識体部の形成方法及びラテラルフロー免疫測定用検査デバイス |
| JP2008268043A (ja) | 2007-04-23 | 2008-11-06 | Denka Seiken Co Ltd | 検査デバイスの検出部の形成方法及びラテラルフロー免疫測定用検査デバイス |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI878683B (zh) | 2025-04-01 |
| JPWO2022259990A1 (https=) | 2022-12-15 |
| WO2022259990A1 (ja) | 2022-12-15 |
| EP4350353A1 (en) | 2024-04-10 |
| US20240272158A1 (en) | 2024-08-15 |
| EP4350353A4 (en) | 2024-06-19 |
| TW202314243A (zh) | 2023-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102209489B1 (ko) | 바이러스 및 박테리아 감염의 복합 검출을 위한 방법 및 장치 | |
| KR102244484B1 (ko) | 당쇄항원을 추출하고 측정하기 위한 이뮤노크로마토그래피 디바이스 | |
| EP2290367A1 (en) | Method for detecting objective substance and kit for detecting objective substance | |
| TW201541080A (zh) | 免疫層析分析試劑盒、免疫層析分析裝置以及免疫層析分析方法 | |
| JP6452491B2 (ja) | イムノクロマト法検査デバイスの試料添加部の形成方法及びイムノクロマト法検査デバイス | |
| WO2017163341A1 (ja) | イムノクロマト法検査デバイスの試料添加部の形成方法及びイムノクロマト法検査デバイス | |
| JP2010032396A (ja) | バイオセンサ | |
| JP7773850B2 (ja) | シグナルの低下を改善した検査試薬 | |
| KR20240019075A (ko) | 분변 검체의 검사 방법 및 그것을 위한 이뮤노크로마토그래피 시험편 | |
| JP4365329B2 (ja) | 複数の被検出物を検出する簡易アッセイ装置及び方法 | |
| KR20240019074A (ko) | 분변 검체의 검사 방법 및 그것을 위한 이뮤노크로마토그래피 시험편 | |
| JP2023078370A (ja) | 疎水性素材に亜硝酸塩又は固形状酸性試薬を含浸させることにより、検体の展開を制御し得る、糖鎖抗原を抽出し測定するためのイムノクロマト試験片 | |
| JP2012137326A (ja) | 検体分析用具 | |
| KR20230062805A (ko) | 위양성의 억제에 의해 특이성을 개선한 검사 키트 | |
| WO2024122616A1 (ja) | イムノクロマト法検査デバイスの試料展開部の形成方法およびイムノクロマト法検査デバイス | |
| KR102813143B1 (ko) | 친수성 소재에 아질산염 또는 고형상 산성시약을 함침시킴으로써, 검체의 전개를 제어할 수 있는, 당쇄항원을 추출하고 측정하기 위한 면역크로마토그래피 시험편 | |
| JP7313830B2 (ja) | 検体の展開を制御し得る、糖鎖抗原を抽出し測定するためのイムノクロマト試験キット | |
| Jesadiya | In vitro Diagnosis in SR BIOERA | |
| JP2010217064A (ja) | クロマトグラフ方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20231106 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250218 Comment text: Request for Examination of Application |